What is Pyxis Oncology 3-Year Share Buyback Ratio?
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Pyxis Oncology's current 3-Year Share Buyback Ratio was -23.00%.
The historical rank and industry rank for Pyxis Oncology's 3-Year Share Buyback Ratio or its related term are showing as below:
PYXS'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -23 Med: -12.1 Max: -3.3
Current: -23
During the past 6 years, Pyxis Oncology's highest 3-Year Share Buyback Ratio was -3.30%. The lowest was -23.00%. And the median was -12.10%.
PYXS's 3-Year Share Buyback Ratio is ranked worse than 72.76% of 1263
companies
in the Biotechnology industry
Industry Median: -9.8
vs PYXS: -23.00
Competitive Comparison of Pyxis Oncology's 3-Year Share Buyback Ratio
For the Biotechnology subindustry, Pyxis Oncology's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pyxis Oncology's 3-Year Share Buyback Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Pyxis Oncology's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Pyxis Oncology's 3-Year Share Buyback Ratio falls into.
Pyxis Oncology 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
Pyxis Oncology (NAS:PYXS) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Pyxis Oncology 3-Year Share Buyback Ratio Related Terms
Thank you for viewing the detailed overview of Pyxis Oncology's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PYXS has been successfully added to your